Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 14 | 2020 | 409 | 1.040 |
Why?
|
| Brain | 10 | 2020 | 331 | 0.930 |
Why?
|
| DNA Methylation | 7 | 2018 | 72 | 0.660 |
Why?
|
| Genome-Wide Association Study | 7 | 2020 | 66 | 0.420 |
Why?
|
| Cognitive Dysfunction | 4 | 2019 | 235 | 0.380 |
Why?
|
| Cognition Disorders | 3 | 2019 | 237 | 0.350 |
Why?
|
| Aging | 4 | 2018 | 352 | 0.330 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2020 | 72 | 0.310 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2018 | 123 | 0.310 |
Why?
|
| Aged, 80 and over | 11 | 2020 | 1034 | 0.300 |
Why?
|
| Aged | 11 | 2020 | 1860 | 0.260 |
Why?
|
| Male | 13 | 2020 | 3399 | 0.250 |
Why?
|
| Female | 13 | 2020 | 3346 | 0.250 |
Why?
|
| Cognition | 3 | 2018 | 337 | 0.250 |
Why?
|
| Prefrontal Cortex | 2 | 2017 | 36 | 0.240 |
Why?
|
| Membrane Transport Proteins | 2 | 2017 | 29 | 0.240 |
Why?
|
| Nuclear Proteins | 2 | 2017 | 30 | 0.240 |
Why?
|
| Humans | 16 | 2020 | 5837 | 0.230 |
Why?
|
| Hippocampus | 3 | 2019 | 61 | 0.190 |
Why?
|
| Memory, Episodic | 2 | 2019 | 26 | 0.180 |
Why?
|
| Perception | 2 | 2019 | 30 | 0.180 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 28 | 0.170 |
Why?
|
| Gene Expression | 2 | 2017 | 64 | 0.160 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 52 | 0.160 |
Why?
|
| Apolipoprotein E4 | 2 | 2017 | 92 | 0.150 |
Why?
|
| Cohort Studies | 5 | 2020 | 406 | 0.150 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 37 | 0.140 |
Why?
|
| Learning | 1 | 2018 | 23 | 0.130 |
Why?
|
| Cognitive Aging | 1 | 2018 | 27 | 0.130 |
Why?
|
| Brain Infarction | 1 | 2017 | 23 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 87 | 0.130 |
Why?
|
| Neurodegenerative Diseases | 1 | 2018 | 39 | 0.130 |
Why?
|
| Neuropsychological Tests | 4 | 2019 | 309 | 0.130 |
Why?
|
| Haplotypes | 1 | 2017 | 19 | 0.130 |
Why?
|
| Receptors, Cell Surface | 1 | 2017 | 8 | 0.130 |
Why?
|
| Neuropeptides | 1 | 2017 | 12 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 15 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2017 | 38 | 0.130 |
Why?
|
| Neuropathology | 1 | 2017 | 17 | 0.130 |
Why?
|
| Smell | 1 | 2016 | 8 | 0.130 |
Why?
|
| Longitudinal Studies | 4 | 2019 | 363 | 0.120 |
Why?
|
| Fetus | 1 | 2016 | 8 | 0.120 |
Why?
|
| Educational Status | 1 | 2016 | 60 | 0.120 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 26 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 66 | 0.120 |
Why?
|
| Antiporters | 1 | 2015 | 4 | 0.110 |
Why?
|
| HLA-DRB5 Chains | 1 | 2015 | 4 | 0.110 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2015 | 6 | 0.110 |
Why?
|
| LDL-Receptor Related Proteins | 1 | 2015 | 6 | 0.110 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2015 | 9 | 0.110 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 21 | 0.110 |
Why?
|
| DNA-Binding Proteins | 3 | 2019 | 94 | 0.100 |
Why?
|
| Amyloid beta-Peptides | 2 | 2020 | 41 | 0.080 |
Why?
|
| Disease Progression | 2 | 2019 | 157 | 0.070 |
Why?
|
| Sclerosis | 2 | 2019 | 26 | 0.070 |
Why?
|
| Autopsy | 2 | 2019 | 67 | 0.070 |
Why?
|
| Lewy Bodies | 2 | 2019 | 56 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 2 | 2018 | 33 | 0.070 |
Why?
|
| Genetic Loci | 2 | 2017 | 16 | 0.060 |
Why?
|
| Genotype | 2 | 2017 | 114 | 0.060 |
Why?
|
| Plaque, Amyloid | 2 | 2017 | 29 | 0.060 |
Why?
|
| Middle Aged | 2 | 2017 | 1775 | 0.050 |
Why?
|
| Epistasis, Genetic | 1 | 2020 | 2 | 0.040 |
Why?
|
| tau Proteins | 1 | 2020 | 36 | 0.040 |
Why?
|
| Fractals | 1 | 2019 | 3 | 0.040 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 10 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 11 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 13 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 2017 | 7 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 11 | 0.030 |
Why?
|
| RNA | 1 | 2017 | 10 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2017 | 22 | 0.030 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2017 | 3 | 0.030 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2017 | 3 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 5 | 0.030 |
Why?
|
| TDP-43 Proteinopathies | 1 | 2017 | 20 | 0.030 |
Why?
|
| Organ Size | 1 | 2017 | 16 | 0.030 |
Why?
|
| Alleles | 1 | 2017 | 89 | 0.030 |
Why?
|
| Memory | 1 | 2017 | 61 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2017 | 21 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 207 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 60 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 7 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 11 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 16 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 14 | 0.030 |
Why?
|
| Chromatin | 1 | 2016 | 7 | 0.030 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2016 | 16 | 0.030 |
Why?
|
| Depression | 1 | 2017 | 113 | 0.030 |
Why?
|
| Child | 1 | 2017 | 339 | 0.030 |
Why?
|
| Risk Factors | 1 | 2017 | 499 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 411 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 421 | 0.030 |
Why?
|
| Biomarkers | 1 | 2016 | 141 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 488 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 32 | 0.030 |
Why?
|
| CpG Islands | 1 | 2015 | 21 | 0.030 |
Why?
|
| United States | 1 | 2016 | 502 | 0.030 |
Why?
|
| Residence Characteristics | 1 | 2015 | 43 | 0.030 |
Why?
|
| Histones | 1 | 2014 | 5 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2014 | 9 | 0.030 |
Why?
|
| Mutation | 1 | 2014 | 101 | 0.030 |
Why?
|
| Adult | 1 | 2017 | 1670 | 0.020 |
Why?
|